Impact of phlebotomy on steatohepatitis
Not Applicable
- Conditions
- onalcoholic steatohepatitis (NASH).Other specified inflammatory liver diseases
- Registration Number
- IRCT20161205031252N4
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
age between 18-65 years
proven steatohepatitis with sonography or fibro scan
Hb more than 13 in men and more than 12 in women
Informed consent
Exclusion Criteria
any other liver disease
history of alcohol use (more than 10gr daily for women and more than 20gr daily for men)
pregnant and lactating women
women in childbearing age with no reliable Contraception method
weight under 50kg
uncontrolled underlying disease
contraindication of vitamin E use
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver fibrosis. Timepoint: before intervention and after 6 month. Method of measurement: fibroscan.;Liver function. Timepoint: before intervention and after 6 month. Method of measurement: Blood samples laboratory study.
- Secondary Outcome Measures
Name Time Method Ferritin level. Timepoint: at the begining of study and 6 months later. Method of measurement: Laboratory blood level measurement.